API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.prnewswire.com/news-releases/microbions-topical-pravibismane-phase-1b-moderate-or-severe-diabetic-foot-ulcer-infection-study-is-published-in-international-wound-journal-302107893.html
https://www.prnewswire.com/news-releases/microbion-presented-new-pravibismane-data-against-mycobacteroides-abscessus-at-the-6th-world-bronchiectasis-and-ntm-conference-301899119.html
https://www.prnewswire.com/news-releases/microbion-corp-granted-us-patent-for-the-use-of-inhaled-pravibismane-for-pulmonary-infections-301788942.html
https://www.prnewswire.com/news-releases/microbion-corporation-initiates-phase-2-clinical-study-evaluating-topical-pravibismane-treatment-of-diabetic-foot-infections-301767435.html
https://www.prnewswire.com/news-releases/microbion-corporation-announces-poster-highlighting-pravibismane-activity-against-common-cystic-fibrosis-pulmonary-pathogens-to-be-presented-at-the-north-american-cystic-fibrosis-conference-2022-301667118.html
https://www.prnewswire.com/news-releases/microbion-corporation-announces-granting-of-a-us-patent-for-a-pharmaceutical-composition-of-pravibismane-301639713.html
https://www.prnewswire.com/news-releases/microbion-corporation-receives-up-to-2-1-million-in-funding-support-from-the-us-navy-in-partnership-with-cubrc-inc-to-advance-topical-pravibismane-301562277.html
https://www.prnewswire.com/news-releases/microbion-corporation-announces-data-highlighting-in-vitro-activity-of-pravibismane-in-ntm-including-activity-against-ntm-causing-intracellular-infections-to-be-presented-at-the-colorado-mycobacteria-conference-2022-301558532.html